Shopping Cart
Remove All
Your shopping cart is currently empty
Etidocaine
Copy Product Info
😃Good
Catalog No. T31716LCas No. 36637-18-0
Etidocaine is an amino acidamide that acts as a local anesthetic with fast onset and long-acting properties.
Etidocaine
Copy Product Info😃Good
Purity: 99.99%
Catalog No. T31716LCas No. 36637-18-0
Etidocaine is an amino acidamide that acts as a local anesthetic with fast onset and long-acting properties.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $117 | In Stock | In Stock | |
| 5 mg | $262 | In Stock | In Stock | |
| 10 mg | $387 | In Stock | In Stock | |
| 25 mg | $592 | In Stock | In Stock | |
| 50 mg | $828 | In Stock | In Stock | |
| 100 mg | $1,110 | In Stock | In Stock | |
| 500 mg | $2,230 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $231 | In Stock | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.99%
Appearance:Solid
Color:White
Contact us for more batch information
Product Introduction
Etidocaine AI Summary
Etidocaine shows a range of bioactivities, notably influencing liver enzymes by increasing alkaline phosphatase, serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), lactate dehydrogenase (LDH), and gamma-glutamyl transferase (GGT), indicating potential effects on liver function. It inhibits the entry of the Ebola virus with an AC50 of 14125.4 nM and an Ac50 of 14.13 µM, and affects nuclear area and viability in VEGF-stimulated ADSC/ECFC co-culture assays with an IC50 of 10000.0 nM. In insulin secretion assays from INS-1E cells (IC50 = 33330.0 nM) and GLP1 secretion assays from STC-1 and NCI-H716 cells (IC50 = 40000.0 nM), it demonstrates moderate activity. Additionally, Etidocaine exhibits low antiviral activity against SARS-CoV-2 based on various assays, showing minimal inhibition in Vero E6 and Caco-2 cells and an IC50 value higher than 20,000 nM. It also demonstrates 14.91% inhibition of SARS-CoV-2 3CL-Pro protease at 20 µM. Furthermore, it exhibits minimal inhibition of human HDAC6 enzyme activity with inhibition rates of -12.37% and -6.64% in enzymatic assays..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Etidocaine is an amino acidamide that acts as a local anesthetic with fast onset and long-acting properties. |
| Molecular Weight | 276.42 |
| Formula | C17H28N2O |
| Cas No. | 36637-18-0 |
| Smiles | N(C(C(N(CCC)CC)CC)=O)C1=C(C)C=CC=C1C |
| Relative Density. | 0.993 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (180.88 mM), Sonication is recommended.  | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Etidocaine | purchase Etidocaine | Etidocaine cost | order Etidocaine | Etidocaine chemical structure | Etidocaine formula | Etidocaine molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.